Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis

References

• Dyson JK, Beuers U, Jones DEJ, Lohse AW, Hudson M. Primary sclerosing cholangitis. Lancet 2018;391:2547–59. doi:10.1016/S0140-6736(18)30300-3
   PubMed Web of Science ®Google Scholar
• Fausa O, Schrumpf E, Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis. 1991;11:31–9. doi:10.1055/s-2008-1040420
   PubMed Web of Science ®Google Scholar
• Loftus EV, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 2005;54:91–6. doi:10.1136/gut.2004.046615
   PubMed Web of Science ®Google Scholar
• Boonstra K, van Erpecum KJ, van Nieuwkerk KM, Drenth JP, Poen AC, Witteman BJ, et al. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2270–6. doi:10.1002/ibd.22938
   PubMed Web of Science ®Google Scholar
• Joo M, Abreu-e-Lima P, Farraye F, Smith T, Swaroop P, Gardner L, et al. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis. A case-control study. Am J Surg Pathol. 2009;33:854–62. doi:10.1097/PAS.0b013e318196d018
   PubMed Web of Science ®Google Scholar
• Zheng HH, Jiang XL. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies. Eur J Gastroenterol Hepatol. 2016;28:383–90. doi:10.1097/MEG.0000000000000576
   PubMed Web of Science ®Google Scholar
• Broomé U, Löfberg R, Lundqvist K, Veress B. Subclinical time span of inflammatory bowel disease in patients with primary sclerosing cholangitis. Dis Colon Rectum. 1995;38:1301–5. doi:10.1007/BF02049156
   PubMed Web of Science ®Google Scholar
• Krugliak Cleveland N, Rubin DT, Hart J, Weber CR, Meckel K, Tran AL, et al. Patients with ulcerative colitis and primary sclerosing cholangitis frequently have subclinical inflammation in the proximal colon. Clin Gastroenterol Hepatol. 2018;16:68–74. doi:10.1016/j.cgh.2017.07.023
   PubMed Web of Science ®Google Scholar
• Lunder AK, Hov JR, Borthne A, Gleditsch J, Johannesen G, Tveit K, et al. Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease. Gastroenterology 2016;151:660–9.e4. doi:10.1053/j.gastro.2016.06.021
   PubMed Web of Science ®Google Scholar
• Foley JH, Conway EM. Cross talk pathways between coagulation and inflammation. Circ Res. 2016;118:1392–408. doi:10.1161/CIRCRESAHA.116.306853
   PubMed Web of Science ®Google Scholar
• Kaiko GE, Chen F, Lai C-W, Chiang I-L, Perrigoue J, Stojmirović A, et al. PAI-1 augments mucosal damage in colitis. Sci Transl Med. 2019;11:eaat0852. doi:10.1126/scitranslmed.aat0852
   PubMed Web of Science ®Google Scholar
• Åberg M, Eriksson O, Siegbahn A. Tissue factor noncoagulant signaling: mechanisms and implications for cell migration and apoptosis. Semin Thromb Hemost. 2015;41:691–9. doi:10.1055/s-0035-1564046
   PubMed Web of Science ®Google Scholar
• Eriksson O, Asplund A, Hegde G, Edqvist PH, Navani S, Ponten F, et al. A stromal cell population in the large intestine identified by tissue factor expression that is lost during colorectal cancer progression. Thromb Haemost. 2016;116:1050–9. doi:10.1160/TH16-04-0267
   PubMed Web of Science ®Google Scholar
• More L, Sim R, Hudson M, Dhillon AP, Pounder R, Wakefield AJ. Immunohistochemical study of tissue factor expression in normal intestine and idiopathic inflammatory bowel disease. J Clin Pathol. 1993;46:703–8. doi:10.1136/jcp.46.8.703
   PubMed Web of Science ®Google Scholar
• Reichman-Warmusz E, Kurek J, Gabriel A, Brzozowa M, Bula G, Helewski K, et al. Tissue hemostasis and chronic inflammation in colon biopsies of patients with inflammatory bowel disease. Pathol Res Pract. 2012;208:553–6. doi:10.1016/j.prp.2012.06.005
   PubMed Web of Science ®Google Scholar
• He HL, Zhang JB, Li Q. Clinical significance of expression of tissue factor and tissue factor pathway inhibitor in ulcerative colitis. WJG. 2014;20:7461. doi:10.3748/wjg.v20.i23.7461
   PubMed Web of Science ®Google Scholar
• Feakins RM, British Society of Gastroenterology. Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines. J Clin Pathol. 2013;66:1005–26. doi:10.1136/jclinpath-2013-201885
   PubMed Web of Science ®Google Scholar
• Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010;51:660–78. doi:10.1002/hep.23294
   PubMed Web of Science ®Google Scholar
• Lampinen M, Waddell A, Ahrens R, Carlson M, Hogan SP. CD14 + CD33+ myeloid cell-CCL11-eosinophil signature in ulcerative colitis. J Leukoc Biol. 2013;94:1061–70. doi:10.1189/jlb.1212640
   PubMed Web of Science ®Google Scholar
• Lampinen M, Rönnblom A, Amin K, Kristjansson G, Rorsman F, Sangfelt P, et al. Eosinophil granulocytes are activated during the remission phase of ulcerative colitis. Gut 2005;54:1714–20. doi:10.1136/gut.2005.066423
   PubMed Web of Science ®Google Scholar
• Palmela C, Peerani F, Castaneda D, Torres J, Itzkowitz SH. Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features. Gut Liver. 2018;12:17–29. doi:10.5009/gnl16510
   PubMed Web of Science ®Google Scholar
• de Vries AB, Janse M, Blokzijl H, Weersma RK. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. WJG. 2015;21:1956–71. doi:10.3748/wjg.v21.i6.1956
   PubMed Web of Science ®Google Scholar
• Gwela A, Siddhanathi P, Chapman RW, Travis S, Powrie F, Arancibia-Carcamo CV, et al. Th1 and innate lymphoid cells accumulate in primary sclerosing cholangitis-associated inflammatory bowel disease. J Crohns Colitis. 2017;11:1124–34. doi:10.1093/ecco-jcc/jjx050
   PubMed Web of Science ®Google Scholar
• Lampinen M, Vessby J, Fredricsson A, Wanders A, Rorsman F, Carlson M. High serum sCD40 and a distinct colonic T-cell profile in ulcerative colitis associated with primary sclerosing cholangitis. J Crohns Colitis. 2019;13:341–50. doi:10.1093/ecco-jcc/jjy170
   PubMed Web of Science ®Google Scholar
• Lampinen M, Fredricsson A, Vessby J, Martinez JF, Wanders A, Rorsman F, et al. Downregulated eosinophil activity in ulcerative colitis with concomitant primary sclerosing cholangitis. J Leukoc Biol. 2018;104:173–83. doi:10.1002/JLB.3MA0517-175R
   PubMed Web of Science ®Google Scholar
• Chu AJ. Tissue factor, blood coagulation, and beyond: an overview. Int J Inflam. 2011;2011:1. doi:10.4061/2011/367284
   Google Scholar
• Anthoni C, Russell J, Wood KC, Stokes KY, Vowinkel T, Kirchhofer D, et al. Tissue factor: a mediator of inflammatory cell recruitment, tissue injury, and thrombus formation in experimental colitis. J Exp Med. 2007;204:1595–601. doi:10.1084/jem.20062354
   PubMed Web of Science ®Google Scholar
• Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134:1087–97.
   PubMed Web of Science ®Google Scholar
• Fleck RA, Rao LV, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res. 1990;59:421–37. doi:10.1016/0049-3848(90)90148-6
   PubMed Web of Science ®Google Scholar
• Flössel C, Luther T, Müller M, Albrecht S, Kasper M. Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue. Histochemistry 1994;101:449–53. doi:10.1007/BF00269495
   PubMedGoogle Scholar
• Kinchen J, Chen HH, Parikh K, Antanaviciute A, Jagielowicz M, Fawkner-Corbett D, et al. Structural remodeling of the human colonic mesenchyme in inflammatory bowel disease. Cell 2018;175:372–86.e17. doi:10.1016/j.cell.2018.08.067
   PubMed Web of Science ®Google Scholar
• Halliday JS, Djordjevic J, Lust M, Culver EL, Braden B, Travis SP, et al. A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn’s disease. J Crohns Colitis. 2012;6:174–81. doi:10.1016/j.crohns.2011.07.015
   PubMed Web of Science ®Google Scholar
• Weismuller TJ, Trivedi PJ, Bergquist A, Imam M, Lenzen H, Ponsioen CY, et al. Patient age, sex, and inflammatory bowel disease phenotype associate with course of primary sclerosing cholangitis. Gastroenterology 2017;152:1975–84 e8.
   PubMed Web of Science ®Google Scholar